127 related articles for article (PubMed ID: 11007696)
21. Switch From Epoetin Beta to Darbepoetin Alfa Treatment of Anemia in Taiwanese Hemodialysis Patients: Dose Equivalence by Hemoglobin Stratification.
Liao SC; Hung CC; Lee CT; Lee CH; Lee CC; Lin CL; Sun CY; Cheng BC; Yang CC; Wu CH; Chen JB
Ther Apher Dial; 2016 Aug; 20(4):400-7. PubMed ID: 27060362
[TBL] [Abstract][Full Text] [Related]
22. Predicting the hematopoietic response to recombinant human erythropoietin (Epoetin alfa) in the treatment of the anemia of cancer.
Adamson JW; Ludwig H
Oncology; 1999; 56(1):46-53. PubMed ID: 9885377
[TBL] [Abstract][Full Text] [Related]
23. The relationship between depressive symptoms and erythropoietin resistance in stable hemodialysis patients with adequate iron stores.
Afsar B
Int J Artif Organs; 2013 May; 36(5):314-9. PubMed ID: 23645578
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness impact of iron dextran on hemodialysis patients' use of epoetin alfa and blood.
Driver PS
Am J Health Syst Pharm; 1998 Dec; 55(24 Suppl 4):S12-6. PubMed ID: 9872688
[TBL] [Abstract][Full Text] [Related]
25. Epoetin alfa: to give or not to give.
Dang C; Hudis C; Norton L
J Natl Cancer Inst; 2013 Jul; 105(14):1001-3. PubMed ID: 23860203
[No Abstract] [Full Text] [Related]
26. [Epoetin alfa: recent strategies of use].
Tumori; 1997; 83(6):975-8. PubMed ID: 9537918
[No Abstract] [Full Text] [Related]
27. Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis.
Thamer M; Zhang Y; Kaufman J; Cotter D; Dong F; Hernán MA
JAMA; 2007 Apr; 297(15):1667-74. PubMed ID: 17440144
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of iron indices in hemodialysis patients receiving epoetin.
Kaufman JS; Reda DJ; Fye CL; Goldfarb DS; Henderson WG; Kleinman JG; Vaamonde CA;
Kidney Int; 2001 Jul; 60(1):300-8. PubMed ID: 11422765
[TBL] [Abstract][Full Text] [Related]
29. Clinicians adjust to latest ESA recommendations.
Traynor K
Am J Health Syst Pharm; 2011 Aug; 68(16):1467, 1472, 1474. PubMed ID: 21817075
[No Abstract] [Full Text] [Related]
30. Focus on epoetin: key findings of mini-sessions.
Semin Oncol; 1998 Jun; 25(3 Suppl 7):69-75. PubMed ID: 9671335
[No Abstract] [Full Text] [Related]
31. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.
Demetri GD; Kris M; Wade J; Degos L; Cella D
J Clin Oncol; 1998 Oct; 16(10):3412-25. PubMed ID: 9779721
[TBL] [Abstract][Full Text] [Related]
32. Standardized doses of epoetin alfa for hemodialysis patients.
Nguyen TV; Iacovino LA
Am J Health Syst Pharm; 2005 Sep; 62(18):1867. PubMed ID: 16141103
[No Abstract] [Full Text] [Related]
33. [Should erythropoietin be administered to old patients in the preoperative period of orthopaedics surgery?].
Páramo Fernández JA
Med Clin (Barc); 2004 Oct; 123(11):421-2. PubMed ID: 15482717
[No Abstract] [Full Text] [Related]
34. Effect of a More Permeable Dialysis Membrane on ESA Resistance in Hemodialysis Patients--A Pilot Investigation.
Teatini U; Liebchen A; Nilsson LG; Beck W; Longhena GR
Blood Purif; 2016; 41(1-3):80-6. PubMed ID: 26536083
[TBL] [Abstract][Full Text] [Related]
35. Successful recombinant erythropoietin therapy for a developing anemic newborn with hereditary spherocytosis.
Hosono S; Hosono A; Mugishima H; Nakano Y; Minato M; Okada T; Takahashi S; Harada K
Pediatr Int; 2006 Apr; 48(2):178-80. PubMed ID: 16635181
[No Abstract] [Full Text] [Related]
36. Cancer-related anaemia requires higher doses of epoetin alfa than chronic renal failure replacement therapy.
Itri LM
Nephrol Dial Transplant; 2001 Dec; 16(12):2289-93. PubMed ID: 11733616
[No Abstract] [Full Text] [Related]
37. A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients.
Furuland H; Linde T; Ahlmén J; Christensson A; Strömbom U; Danielson BG
Nephrol Dial Transplant; 2003 Feb; 18(2):353-61. PubMed ID: 12543892
[TBL] [Abstract][Full Text] [Related]
38. Targeting anemia with erythropoietin during critical illness.
Cook D; Crowther M
N Engl J Med; 2007 Sep; 357(10):1037-9. PubMed ID: 17804850
[No Abstract] [Full Text] [Related]
39. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.
Glaspy J; Bukowski R; Steinberg D; Taylor C; Tchekmedyian S; Vadhan-Raj S
J Clin Oncol; 1997 Mar; 15(3):1218-34. PubMed ID: 9060566
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin in patients with ST-segment elevation myocardial infarction.
Chen Y
JAMA; 2011 Aug; 306(7):705-6; author reply 706. PubMed ID: 21846847
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
